Literature DB >> 8798750

Dual leucine zipper-bearing kinase (DLK) activates p46SAPK and p38mapk but not ERK2.

G Fan1, S E Merritt, M Kortenjann, P E Shaw, L B Holzman.   

Abstract

Because the catalytic domain of dual leucine zipper-bearing kinase (DLK) bears sequence similarity to members of the mitogen-activated protein (MAP) kinase kinase kinase subfamily, this protein kinase was investigated for its ability to activate MAP kinase pathways. When transiently transfected and overexpressed in either COS 7 cells or NIH3T3 cells, wild type DLK potently activated p46(SAPK) (SAPK/JNK) but had no detectable effect in activating p42/44(MAPK). DLK also activated p38(mapk) when overexpressed in NIH3T3 cells. A catalytically inactive point mutant of DLK had no effect in these experiments. Consistent with its specificity in activating SAPK, DLK activated Elk-1 but not Sap1a-mediated transcription. In NIH3T3 cells, activation of SAPK by v-Src was markedly attenuated by coexpression of K185A, a catalytically inactive mutant of DLK, suggesting that this mutant could function in a dominant negative fashion in a pathway that leads from v-Src to SAPKs. In a series of co-transfection experiments, activation of p46(SAPK) by DLK was not inhibited by dominant negative mutants of Rac1 and Cdc42Hs, PAK65-R, or PAK65-A, but was attenuated by MEKK1(K432M). DLK(K185A) did not inhibit the ability of constitutively active MEKK1 to activate SAPK. Moreover, K185A significantly inhibited the activation of SAPK by constitutively active V-12 Rac1 and V-12 Cdc42Hs. These results suggest that DLK lies distal to Rac1 and/or Cdc42Hs but proximal to MEKK1 in a pathway leading from v-Src to SAPKs activation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8798750     DOI: 10.1074/jbc.271.40.24788

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  39 in total

1.  Transient global cerebral ischemia induces up-regulation of MLTKα in hippocampal CA1 neurons.

Authors:  Xing Su; Chang-Lai Zhu; Wei Shi; Lan-Chun Ni; Jian-Hong Shen; Jian Chen
Journal:  J Mol Histol       Date:  2011-12-07       Impact factor: 2.611

2.  Dual leucine zipper kinase is required for retrograde injury signaling and axonal regeneration.

Authors:  Jung Eun Shin; Yongcheol Cho; Bogdan Beirowski; Jeffrey Milbrandt; Valeria Cavalli; Aaron DiAntonio
Journal:  Neuron       Date:  2012-06-21       Impact factor: 17.173

Review 3.  The ERK cascade: a prototype of MAPK signaling.

Authors:  Hadara Rubinfeld; Rony Seger
Journal:  Mol Biotechnol       Date:  2005-10       Impact factor: 2.695

4.  Evidence for a role of mixed lineage kinases in neuronal apoptosis.

Authors:  M Mota; M Reeder; J Chernoff; C E Bazenet
Journal:  J Neurosci       Date:  2001-07-15       Impact factor: 6.167

5.  Mixed lineage kinase-dependent JNK activation is governed by interactions of scaffold protein JIP with MAPK module components.

Authors:  D Nihalani; D Meyer; S Pajni; L B Holzman
Journal:  EMBO J       Date:  2001-07-02       Impact factor: 11.598

Review 6.  The p38 mitogen-activated protein kinase (MAPK) pathway in rheumatoid arthritis.

Authors:  G Schett; J Zwerina; G Firestein
Journal:  Ann Rheum Dis       Date:  2007-09-07       Impact factor: 19.103

7.  Inhibition of membrane depolarisation-induced transcriptional activity of cyclic AMP response element binding protein (CREB) by the dual-leucine-zipper-bearing kinase in a pancreatic islet beta cell line.

Authors:  E Oetjen; A Lechleiter; R Blume; D Nihalani; L Holzman; W Knepel
Journal:  Diabetologia       Date:  2005-12-21       Impact factor: 10.122

8.  The MKK7 gene encodes a group of c-Jun NH2-terminal kinase kinases.

Authors:  C Tournier; A J Whitmarsh; J Cavanagh; T Barrett; R J Davis
Journal:  Mol Cell Biol       Date:  1999-02       Impact factor: 4.272

9.  Drosophila C-terminal Src kinase negatively regulates organ growth and cell proliferation through inhibition of the Src, Jun N-terminal kinase, and STAT pathways.

Authors:  Renee D Read; Erika A Bach; Ross L Cagan
Journal:  Mol Cell Biol       Date:  2004-08       Impact factor: 4.272

Review 10.  Mitogen-activated protein kinases: a new therapeutic target in cardiac pathology.

Authors:  Tána Ravingerová; Miroslav Barancík; Monika Strnisková
Journal:  Mol Cell Biochem       Date:  2003-05       Impact factor: 3.396

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.